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Abstract
Background: The majority of atypical bovine spongiform encephalopathy (BSE) cases so far identified worldwide
have been detected by active surveillance. Consequently the volume and quality of material available for detailed
characterisation is very limiting. Here we report on a small transmission study of both atypical forms, H- and L-type
BSE, in cattle to provide tissue for test evaluation and research, and to generate clinical, molecular and pathological
data in a standardised way to enable more robust comparison of the two variants with particular reference to
those aspects most relevant to case ascertainment and confirmatory diagnosis within existing regulated
surveillance programmes.
Results: Two groups of four cattle, intracerebrally inoculated with L-type or H-type BSE, all presented with a
nervous disease form with some similarities to classical BSE, which progressed to a more dull form in one animal
from each group. Difficulty rising was a consistent feature of both disease forms and not seen in two BSE-free,
non-inoculated cattle that served as controls. The pathology and molecular characteristics were distinct from
classical BSE, and broadly consistent with published data, but with some variation in the pathological
characteristics. Both atypical BSE types were readily detectable as BSE by current confirmatory methods using the
medulla brain region at the obex, but making a clear diagnostic distinction between the forms was not
consistently straightforward in this brain region. Cerebellum proved a more reliable sample for discrimination when
using immunohistochemistry.
Conclusions: The prominent feature of difficulty rising in atypical BSE cases may explain the detection of naturally
occurring cases in emergency slaughter cattle and fallen stock. Current confirmatory diagnostic methods are
effective for the detection of such atypical cases, but consistently and correctly identifying the variant forms may
require modifications to the sampling regimes and methods that are currently in use.
Background
After bovine spongiform encephalopathy (BSE) was first
described as a novel neurological disease in cattle in the
United Kingdom (UK) more than 20 years ago [1], sub-
sequent research indicated that it was caused by a single
agent based on the clinical [2], pathological [3], molecu-
lar [4,5] and biological [6] phenotype. Experimental
inoculation of cattle with agents found in transmissible
spongiform encephalopathies (TSEs) of other species,
such as scrapie [7-9] or chronic wasting disease [10],
produced a neurological disease, but in each case the
disease was different phenotypically from BSE. The
introduction of active surveillance in various countries
has resulted in the detection of other, putatively spora-
dic, forms of BSE in cattle which were characterised by
different neuropathological [bovine amyloidotic spongi-
form encephalopathy (BASE)] [11] or molecular features
(L-type and H-type BSE) [12-16] and affected mainly
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prion protein fragments visualised on a Western immu-
noblot after proteinase digestion of brain tissue from
affected animals, the molecular mass was either lower
( L - t y p eB S E ,a l s ok n o w na sB A S E )o rh i g h e r( H - t y p e
BSE) than in the classical form of BSE (C-type BSE).
Both forms of atypical BSE were subsequently also iden-
tified in the United Kingdom (UK) [17,18]. To date,
none of these ‘atypical’ BSE cases diagnosed in various
countries in cattle (Bos taurus) have been reported as
clinical suspects, suggesting that the diseases are differ-
ent from classical BSE. Indeed, transmission studies in
cattle produced a disease characterised by signs of dull-
ness and difficulty in rising that maintained its molecu-
lar phenotype difference to C-type BSE [19,20].
Most of the cases that have so far been identified
worldwide [17] were detected through active surveil-
lance programmes. Consequently the volume and quality
of material available for detailed characterisation is very
limiting due to only medulla at the obex being collected
for statutory diagnosis or, particularly in the case of
fallen stock, the tissue is badly autolysed.
With the exception of the first reported L-type BSE
case [11] there are no field cases in which combined
biochemical and pathological findings throughout the
brain or peripheral tissues as well as clinical data have
been described, to provide a full phenotypic picture of
either H or L variants.
The transmissibility of these variant forms has been
previously established in experimental models, both in
rodents [21-25] where the phenotype was not consis-
tently stable, and in the natural host [19,20,26,27], in
different laboratories.
Here, we report on a small transmission study in cat-
tle by the intracerebral route, which was initiated in the
UK as part of the activities of the European Union (EU)
reference laboratory, to provide tissue for test evaluation
and research, and to generate clinical, molecular and
pathological data in a standardised way to enable more
robust comparison of the two variants. This paper
informs on the clinical, pathological and molecular char-
acteristics of L-type and H-type BSE with particular
reference to those aspects most relevant to case ascer-
tainment and confirmatory diagnostic sensitivity and
specificity within existing regulated surveillance
programmes.
Results
Animal data and clinical disease
All cattle (H1-4, inoculated with H-type BSE; L1-4,
inoculated with L-type BSE and CO1-2, non-inoculated
controls) were homozygous for six octapeptide repeats
(6:6) and carried silent single nucleotide sequence poly-
morphisms at codon 78 [L2, H1, H3-4 (heterozygous),
CO2 (homozygous)], codon 113 [L1, L3-4, H1-2, CO1
(heterozygous)] or codon 192 [L2 (heterozygous)]. Times
of clinical onset and death are indicated in Figure 1.
The clinical presentation appeared to be similar in
both H- and L-type BSE-affected cattle. Selected signs of
changes in behaviour and mental status, sensation and
locomotion observed over time are displayed in Figure
1, which also shows the findings in controls for compar-
ison. The estimated clinical onset was based on the pre-
sence of difficulty in rising (H2), in combination with
regular unexpected startle (H1 and L4) or with sus-
pected gait abnormality (H3), or the presence of beha-
vioural and sensory changes (L1-3 and H4).
Animal H2 injured itself when caught between hurdles
in the pen, which resulted in culling at an earlier clinical
stage compared to the others.
Changes in behaviour, activity, mental status and sensation
All inoculated cattle displayed signs of a ‘nervous disease
form’, characterised by over-reactivity to external sti-
muli, apprehension or anxiety (see Additional file 1: ‘H-
type BSE (H1)’ and Additional file 2: ‘L-type BSE (L1)’
showing over-reactivity and apprehension during the
examination). First noticeable from 8-11 months post
inoculation (mpi) were restlessness and head shyness
when the cattle were approached from the front whilst
restrained in a crush, characterised by sudden backing
off, head shaking or head tossing. Contrary to the con-
trol cattle that also displayed this behaviour around that
time, the BSE-infected cattle continued to display this
sign on subsequent examinations, which was also
accompanied by sensory changes, such as increased
over-reactivity to tactile facial stimuli (head tossing,
nose wrinkling, snorting) or visual stimuli (jerking, tos-
sing or shaking of the head) during assessment of cra-
nial nerve function [compare signs ‘head shyness’ and
‘over-reactivity to tactile stimuli’ between H/L-type BSE
cases and controls in Figure 1; see also Additional file 3:
‘Control (CO1)’, which shows the lack of over-reactivity
in this control animal prior to cull]. There was also a
noticeable change in the behaviour when the animals
were released in the corridor: they became more reluc-
tant to move in the corridor, stopping at grooves on the
floor [see Additional file 1: ‘H-type BSE (H1)’ of this
steer stopping at grooves on the floor], whereas they
had previously been curious and active in the corridor
like the control cattle [see Additional file 3: ‘control
(CO1)’ showing this control animal running along the
corridor and stopping to sniff objects]. Behavioural or
sensory changes also included the increased occurrence
of startle reactions, spontaneously or in response to sud-
den external stimuli, which were not observed in control
cattle [compare the occurrence of ‘unexpected startle’
between H/L-type BSE cases and controls in Figure 1;
see also Additional file 4: ‘H-type BSE (H4a)’ showing a
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Page 2 of 14Figure 1 Selected clinical signs observed over time in L- and H-type BSE cases compared to controls. Signs are derived from
observations and examinations. The horizontal axis represents the time points when neurological examinations were carried out; a symbol at a
particular time point indicates that the sign was observed between this and the previous time point. The orange dotted lines indicate the time
of estimated clinical onset, the light brown interrupted lines the time of death. Head shy/restless in crush: e.g. head tossing or backing off when
faced in crush. Over-reactive to tactile stimuli: e.g. head tossing in response to touching of the head. Abnormal tests of over-reactivity: startle at
flash, clipboard test or hand clap, kicking on stick test. Abnormal gait: e.g. dysmetria.
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Page 3 of 14steer with startle compared to a control in similar cir-
cumstances]. Repeated startle in response to tests of
over-reactivity (e.g. flash test, clipboard test) was how-
ever not or not consistently observed, similar to control
cattle (see Figure 1). Forceful kicking in response to
touching of the hind limbs with a flexible stick was only
observed in an L-type BSE-inoculated heifer (L2).
O n eH - t y p eB S E - i n o c u l a t e ds t e e r( H 3 )h a da‘panic
attack’ at 19 mpi: it panicked during cleaning of the
pen, ran into the hay rack and the wall of the pen,
slipped after circling in the pen and fell to the floor in
lateral recumbency with its legs thrashing for approxi-
mately 90 seconds. It subsequently remained still in the
same position for approximately 5 minutes before right-
ing itself. The steer eventually got up 3 minutes later
rising with its forelimbs first.
Two cattle (H1 and L2) developed marked distress to
restraining of the head, characterised by open-mouthed
roaring prior to cull.
Having initially displayed the ‘nervous form’ the last
remaining animal in each group (L4 and H4) later devel-
oped a more ‘dull disease form’ from 21 mpi, where the
initial over-reactivity to tactile stimuli disappeared and
the animal appeared less interested in its surroundings,
sometimes standing in the pen with its head lowered
[see Additional file 5: ‘H-type BSE (H4b)’,w h i c hs h o w s
this animal standing with low head carriage and little
over-reactivity to tactile stimuli].
Changes in gait and coordination
All atypical BSE-infected cattle developed difficulty in
rising, which usually coincided with the development of
gait deficits (see Figure 1), predominantly hind limb
hypermetria [see Additional files 1: ‘H-type BSE (H1)’,
2:’ L-type BSE (L1)’ and 5: ‘H-type BSE (H4b)’ showing
all animals with difficulty in rising (score 2) prior to
cull; hind limb hypermetria is also evident in L1]. Diffi-
culty in rising was not always consistently displayed
after it was first observed; there could be a period of up
to five weeks of normal rising behaviour when weekly
camera observations were analysed, although it became
more regular when cattle displayed score 2 (obvious dif-
ficulty in getting up). Heifer L3 was found in lateral
recumbency, unable to right itself at 21 mpi, although it
managed to get up when placed into sternal position.
Altered lying down behaviour was observed in all H-
type BSE-inoculated cattle and one L-type BSE-inocu-
lated steer (L4) at some time during the incubation per-
iod (usually only once and never at the last camera
observation prior to cull) scoring 3 in three and 2 in
two (H4 and L4) cattle. It was also observed once in the
control steer (score 3).
Tremor was not displayed in any of the cattle
throughout the course of the disease. Loss of weight or
bodily condition was not a consistent feature and only
observed prior to cull in one L-type (L1) and two H-
type BSE affected cattle (H1-2).
Haematology and blood biochemistry
Serum aspartate aminotransferase (AST) and creatine
kinase (CK) activity were increased in two H-type BSE
cases, the injured H2 and H3, which was culled shortly
after the thrashing episode during the ‘panic attack’:A S T
activity was 492 units/l in H2 and 156 units/l in H3, com-
pared to the reference range of 78-132 units/l. CK activity
was 104,133 units/l in H2 and 2,136 units/l in H3, with a
reference range of 35-280 units/l. H2 also presented with
neutrophilia (14,900/μl; reference range: 600-4,000/μl).
One control and two L-type BSE cases had reduced
blood manganese (reference range: 330-350 nmol/l):
CO1: 80 nmol/l, L3: 83 nmol/l and L4: 89 nmol/l.
Postmortem test findings
Vacuolar lesions consistent with TSE were observed
throughout the neuraxis in both the H-type and L-type
BSE cases. At the obex, the neuroanatomical distribution
of vacuolation, and its appearance, were not distinguish-
able from C-type BSE (Figure 2). However, the amount
of vacuolation, relative to observations in positive con-
trol animals challenged with C-type BSE by the same
route (data from previous studies [9]), appeared to be
increased in more rostral brain areas, noticeably the
frontal cortex.
Immunohistochemical examination
Immunolabelling was widespread throughout the neur-
axis in both the H- and L-type BSE cases, but with pat-
terns of immunolabelling that were distinct from one
another and distinguishable from that seen in C-type
BSE [5,28] (Figure 3). As reported previously [11] the L-
type cases showed extensive small plaque-like deposits
throughout the cortical white matter, with moderate
amounts of particulate immunolabelling in the neuropil
(Figure 3). Perineuronal labelling was also prominent.
Another striking feature of the L-type BSE cases was the
immunolabelling in the cerebellum, with a very homoge-
neous involvement of both the molecular and granular
layers, reminiscent of the pattern described for atypical
scrapie in sheep. By comparison, H-type BSE cases
showed fewer plaque-like deposits, and the grey matter
of the cerebral cortex displayed prominent stellate label-
ling in addition to particulate forms (Figure 3). The
labelling in the molecular and granular layers of the cer-
ebellum was minimal and less uniformly distributed. In
the H-type BSE cases, the most striking immunohisto-
chemical feature was widespread glial labelling through-
out the white matter of the spinal cord (Figure 4) and
the cerebellum (Figure 3).
At the obex, the amount and distribution of immuno-
labelling made it difficult to see obvious differences
Konold et al. BMC Veterinary Research 2012, 8:22
http://www.biomedcentral.com/1746-6148/8/22
Page 4 of 14Figure 2 Vacuolation and PrP
d immunolabelling in the solitary tract nucleus of classical and atypical BSE cases. a-c) Haematoxylin and
eosin (H&E) stained sections. d-f) Sections immunolabelled with monoclonal antibody (mAb) R145. Comparison of a C-type BSE case
(intracerebrally inoculated case 163/95; a and d) with an L-type BSE case (L3; b and e) and an H-type BSE case (H1; c and f). In all three cases
vacuolation is present, and immunolabelling is extensive and presents with particulate neuropil labelling as the predominant form.
Figure 3 PrP
d immunolabelling in cerebellum and frontal cortex of classical and atypical BSE cases. Immunolabelling with mAb R145. a-
c) Cerebellum of C-type BSE (intracerebrally inoculated case 163/95; a), L-type BSE (L1; b) and H-type BSE (H3; c). e-f) Frontal cortex of C-type
BSE (163/95; d), L-type BSE (L3; e), and H-type BSE (H3; f). Of particular interest in the cerebellum is the diffuse and even involvement of both the
molecular and granular layers in L-type BSE, while in the cerebellum of the H-type BSE case the most pronounced labelling is in the white
matter. In the cortex small aggregated deposits, mostly in the white matter, predominate in the L-type BSE case, while the H-type BSE case
resembles the classical BSE case with stellate forms throughout the cortical grey matter.
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tion revealed phenotype-specific features in this area
too, specifically labelling in white matter tracts (Figure
4a) in the H-type BSE cases, and small aggregated forms
of immunolabelling (Figure 4b) throughout the reticular
formation in L-type BSE cases.
Widespread immunolabelling was seen throughout the
dorsal and ventral horns at all levels of the spinal cord
as in C-type BSE.
Immunolabelling was also present in the muscle spin-
dles of the extraocular muscles and in the trigeminal
ganglion of both types. Where muscle spindles were
found in other muscles (triceps in one H-type BSE case,
and medial gluteal in one L-type BSE case) these were
also immunolabelled.
No immunolabelling was observed in the lymphoid
tissues or the enteric nervous system in any of the chal-
lenged animals.
Western immunoblot examination
Western immunoblot was carried out on fresh medulla
tissue from each of the eight challenged animals. The
four H-type BSE challenged animals showed the charac-
teristic profile of the proteinase-resistant fragment of
the disease-associated prion protein (PrP
res)a s s o c i a t e d
with this form of disease; a high molecular mass migra-
tion of the unglycosylated band with mAb SHA31, a
similar intensity of signal with mAb P4, and a down-
ward shift of the PrP
res bands with an additional low
molecular mass band observed with mAb SAF84 (Figure
5). The four L-type BSE challenged animals were less
easily distinguished as the migration of the unglycosy-
lated PrP
res band was similar to the classical BSE control
when detected with mAbs SHA31 and SAF84, and they
were also not detected with mAb P4. L-type BSE is also
expected to have an increase in the proportion of the
monoglycosylated band or a more equal distribution of
PrP
res between the di and monoglycosylated bands.
Although this characteristic was present in all four
samples, visually the difference was very subtle, and
when the signal intensity of a sample was particularly
strong the difference was not readily observed until the
sample had been diluted (Figure 6). Glycoform analysis
of the relative quantity of the di- versus monoglycosy-
lated bands confirmed the difference between the L-type
BSE cases and the C-type BSE control (Figure 7).
When disease-associated prion protein (PrP
d)f r o mC -
and L-type BSE cases is digested under two proteinase K
(PK) conditions, mild and stringent, PrP
res from C-type
BSE remains intact whereas PrP
d from L-BSE is largely
destroyed in the stringent preparation. The four L-type
BSE samples were digested using stringent PK treatment
whereas the classical BSE control samples were not.
When the optical density ratios for the immunoblots pro-
duced using mild and stringent PK conditions were dis-
played by a bar chart the C-type BSE controls were above
Figure 4 Differences in PrP
d immunolabelling between L-type
and H-type BSE. Immunolabelling with mAb 145, which can be
used to distinguish H- and L-type forms of disease at the level of
the obex. a) Labelling of the oligodendroglia in the pyramidal tract
in an H-type BSE case (H3). b) Aggregated forms within the reticular
formation of an L-type BSE case (L3).
Figure 5 Western immunoblot of medulla samples from the
four H-type BSE recipients using three different antibodies.A :
mAb SHA31, B: mAb SAF84, C: mAb P4. Lane Key: M Molecular mass
marker. 1 Classical scrapie control 1:2 dilution. 2 C-type BSE control
1:40 dilution. 3 Blank lane. 4 H1. 5 H2. 6 H3. 7 H4.
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Page 6 of 140.7 whilst the L-type BSE cases were below 0.6, irrespec-
tive of which of the three antibodies was used (Figure 8).
Overall, the results for these samples conformed to the
recognised criteria for L-type BSE [12].
Discussion
Classical BSE was first described as a novel neurological
disease in cattle, which displayed overt clinical signs
characterised by changes in behaviour, sensation and
locomotion [1], which led to reporting of many clinical
cases in the UK [29]. Atypical BSE, by contrast, has so
far not been confirmed in clinical suspects: it has been
found in either apparently healthy cattle at abattoirs,
cattle that were subject to emergency slaughter or in
fallen stock and may suggest that the clinical presenta-
tion is different to C-type BSE. Indeed, previously pub-
lished experimental transmission studies of atypical BSE
to cattle conducted elsewhere describe H-type and L-
type BSE as diseases characterised by dullness, low head
carriage, inactivity or lack of nervousness whereas cattle
with classical BSE presented with nervousness or anxiety
and hypersensitivity to various external stimuli
Figure 6 Western immunoblot of medulla samples from the L-
type BSE donor animal and the four recipients using four
different antibodies. A: mAb SHA31, B: mAb 6H4, C: mAb F99, D:
mAb P4. Samples were loaded neat and at dilutions indicated in the
key. Lane Key: M Molecular mass marker. 1 Donor neat. 2 Donor 1:20. 3
D o n o r1 : 4 0 .4L 1n e a t .5L 11 : 1 0 .6L 2n e a t .7L 21 : 1 0 .8L 3n e a t .9L 3
1:20. 10 L4 neat. 11 L4 1:10. 12 C-type BSE control neat. 13 C-type BSE
control 1:20. 14 C-type BSE control 1:40. 15 Standard bovine C-type
BSE control 1:40. 16 Standard ovine scrapie control 1:2.
Figure 7 Glycoform profiles for all four L-type BSE recipients compared to C-type BSE and scrapie using mAb SHA31. The glycoform
profiles in this scattergram are displayed as the percentage signal of the diglycosylated protein band plotted against that of the
monoglycosylated band. The percentage of diglycosylated PrP
res is reduced in L-type BSE cases compared to C-type BSE or classical scrapie.
Figure 8 Bar chart of proteinase K susceptibility signal ratio in
L-type recipients compared to C-type BSE using three different
antibodies. The PK susceptibility signal ratio is < 0.6 for all four L-
type BSE recipients and > 0.7 for the C-type BSE control sample.
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or other external stimuli was also observed in H- or L-
type BSE although the study did not use unchallenged
controls for comparison with clinically ‘normal’ cattle
[19,27]. The clinical signs in the study reported here
r e s e m b l e dt h o s eo b s e r v e di nt h eG e r m a ns t u d y[ 2 7 ] ,
with no difference in the clinical presentation between
H-type and L-type BSE, but separation from other cattle
and low head carriage suggestive of dullness were not a
consistent finding. In fact, the majority of cattle in the
current study showed no signs of dullness, even on
closed circuit television observations, but were over-
reactive, characterised by over-reactivity to tactile facial
and visual stimuli (menace response testing) and dis-
played unexpected startle responses throughout the clin-
ical phase. Cattle intracerebrally inoculated with
classical BSE were not included but previous transmis-
sion studies of classical BSE in Holstein-Friesian cattle
c o n d u c t e da tt h eV e t e r i n a r yLaboratories Agency con-
firmed that over-reactivity and nervousness were a fea-
ture of classical BSE [19,20,30]. There is, however,
variation in the severity of behavioural and sensory
changes in cattle intracerebrally infected with classical
BSE, particularly influenced by the frequent handling of
cattle in experimental studies, which may lead to habi-
tuation to clinical tests. In the authors’ opinion, the ‘ner-
vous syndrome’ of cattle inoculated with atypical BSE
has some resemblance to the clinical presentation of
classical BSE in some cattle [30]. Notably different to
classical BSE were, however, the absence of tremor in all
atypical BSE cases, both H- and L-type, and the pre-
sence of difficulty in rising, accompanied by dysmetria,
early in the disease. In the experimental cases produced
in the Italian study (L-type BSE), difficulty in rising and
ataxia were surprisingly rare and not observed, respec-
tively [19], even though the inoculum in the present
study was also derived from an Italian BASE case.
We previously employed identical clinical methods to
describe ovine scrapie transmitted to cattle, which also
presented with a dull (low head carriage and head rest-
ing against objects) and nervous form (nervousness and
over-reactivity), and all cattle developed difficulty in ris-
ing [9]. Different prion strains in cattle appear to pro-
duce two main clinical phenotypes (dull and nervous
form), with classical BSE being the most uniform and -
with respect to over-reactivity - clinically the most
extreme phenotype.
None of the cattle inoculated with atypical BSE in the
current study progressed to permanent recumbency,
which has been reported to occur within few days after
the display of evident ataxia [27], even though they all
had difficulty in rising. If this is a consistent feature of
atypical BSE whereas over-reactivity is present in a
milder form than classical BSE, it would explain why
case reports of naturally occurring atypical BSE describe
this disease in downer cows [14,17,31].
Our previous recommendation to detect classical BSE
cases in recumbent casualty slaughter cattle on clinical
grounds using the display of repeated startle responses
to tests of over-reactivity and abnormal limb position in
combination with low heart rate or poor body condition
as criteria [32] may not have detected the atypical BSE
cases in the present study but they were culled prior to
permanent recumbency. None of the affected cattle
were bradycardic at clinical end-stage (heart rate not
determined for case H-2) as reported separately [33] but
unexpected startle was observed. Hence, atypical BSE
should be considered as differential diagnosis in any
recumbent animal, which - based on naturally occurring
cases [17] - is 8 years of age or older and has a history
of or presents with over-reactivity to various external
stimuli.
The clinical duration of atypical BSE in the current
study was 4-10 months for L-type BSE and 2-7 months
for H-type BSE, which is considerably longer than
reported by others [19,20,27] except for an experimental
H-type BSE study in Japan [26]. As the survival times or
incubation periods (time from inoculation to cull at
clinical end-stage) and pathology were similar, the dis-
crepancy with other studies may be explained by the dif-
ficulty in defining the exact clinical onset, which is made
retrospectively and based on the presence of various
clinical parameters, which may overlap with those seen
in ‘normal’ cattle. For example, the presence of marked
over-reactivity to touch, which diminished on subse-
quent observations, was also seen in control cattle.
However, startle responses to unexpected (familiar) sti-
muli were not seen in controls and hence - when dis-
played in combination with other signs, e.g. head
shyness - were interpreted as sign indicating clinical
onset. Similarly, difficulty in rising was only seen in
inoculated cattle and thus also used as a marker for
clinical onset. On the other hand, it is possible that the
differences in the clinical duration were attributable to
the particular cattle breeds used in each study. Indeed, a
significantly shorter clinical duration (and incubation
period) was reported for Holstein-Friesian cattle com-
pared with Alpine brown cattle intracerebrally inocu-
lated with BASE brain [19]. Analysis of the clinical
picture of classical BSE using surveillance data has
shown that some statistically significant differences in
the clinical sign frequency may exist between different
herd types (beef and dairy cattle) and different breeds of
dairy cattle [29], which may be due to different methods
of management or due to the different temperaments of
cattle. However, it is difficult to conclude that there are
indeed breed-specific differences in the clinical presenta-
tion since the display of individual signs can generally be
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ducted [34], and depend on other factors, such as dura-
tion of illness and age at onset [29].
PrP genotyping revealed that all cattle had six octa-
peptide repeats and no novel polymorphisms were
detected. The only mutations detected were ‘silent’ in
that they do not affect the PrP protein sequence. The
lack of wild type sequences and the comparatively high
number of cattle with the P113 silent mutation (found
in only three of 118 Holstein-Friesians examined in the
UK [35]) was unusual but may be due to the breed stu-
died; its occurrence was higher in a study of predomi-
nantly beef breeds in the United States [36].
T h ed e v e l o p m e n to ft h ed u l ls y n d r o m ei no n l yt h o s e
cattle that had the longest clinical duration but pre-
v i o u s l ye x h i b i t e dt h en e r v o u ss y n d r o m em a ys u g g e s t
that all infected cattle might have eventually developed
the dull syndrome. Based on the range of clinical signs
displayed by all cattle prior to cull, which was consid-
ered to be the clinical end-point, there was however no
evidence that the cattle exhibiting the dull syndrome
were in a more advanced stage of disease than the cattle
exhibiting the nervous syndrome at cull. The display of
either the nervous or dull syndrome at end-stage in
both inoculation groups did not appear to be influenced
by the prion protein genotype: both syndromes were
displayed by cattle with the same genotype. Equally, the
observed differences did not appear to have been attri-
butable to gender. As the majority of the brain from
both cattle with the dull syndrome was frozen, it was
not possible to determine whether the pathological phe-
notype was different; accumulation of the disease-asso-
ciated prion protein (PrP
d)a tt h el e v e lo ft h eo b e xw a s
similar for all cases. The lack of association between
clinical presentation and PrP
d accumulation in the brain
has been previously described for scrapie in cattle [9]
and goats [37].
Contrary to the findings reported for BASE/L-type
B S Ei nt h eI t a l i a ns t u d y ,w ed i dn o to b s e r v em u s c l e
atrophy preceded by fasciculations, which were attribu-
ted to a lower motor neuron disease [19]. Serum CK
and AST, which are useful in the diagnosis of diseases
of the muscle, even though they may not provide infor-
mation about the origin (myopathy or neuropathy) [38],
were only altered in two cattle that had muscular
damage due to trauma. The finding of behavioural, sen-
sory and locomotor signs in cattle in the present study
is suggestive of a brain disease, with dysmetria likely to
be caused by cerebellar dysfunction. The ‘panic attack’
of one L-type BSE-inoculated steer, which thrashed its
legs about whilst in lateral recumbency, could even be
interpreted as cerebellar convulsions triggered by sud-
den disturbance [39]. However, other cerebellar signs,
such as an abnormal menace response or intention
tremor, were not observed. The dysmetric limb move-
ments were also not considered to be so severe that
they would have caused difficulty in rising - cerebellar
diseases do not cause loss of muscle strength [40] -
although rising with the forelimbs first, which was seen
occasionally, is suggestive of some inability to coordinate
the movements to stand. The hind limb joints were
inspected in five atypical BSE cases and both controls
and - with the exception of one H-type BSE case (H1)
that presented with mild joint degeneration of both sti-
fles - none presented with abnormalities that would
have explained the observed gait abnormalities. PrP
d
immunolabelling was observed throughout the spinal
cord of both L-type and H-type BSE cases, although this
also occurs in experimentally infected, classical BSE
cases without causing difficulty rising [28]. H-type BSE
cases presented with marked PrP
d accumulation in glia
within the white matter at every level examined but
there was no apparent difference in the observed gait
changes between L-type and H-type BSE cases.
Elevated blood manganese has been reported for cattle
experimentally infected with classical BSE [41]. A similar
phenomenon was not observed in the present study
where two L-type BSE cases had abnormally low levels
of blood manganese, similar to one control.
For the purposes of active screening and confirmatory
diagnosis it is reassuring that the obex is involved in
both H- and L-type BSE, even after intracerebral inocu-
lation of cattle, but it is concerning that discriminating
phenotypically between the different forms is not neces-
sarily straightforward if only the brainstem (obex) is
available, despite significant qualitative differences in
other areas of the brain. This may in part be due to the
large quantities of PrP
d which have accumulated as a
consequence of this experimental challenge being intra-
cerebral, since immunolabelling in the brainstem of field
cases has been reported to be much less, for the L-type
in particular [11,42], although it may also be a result of
these animals being allowed to progress to clinical end-
stage, rather than being killed for other reasons, and
possibly detected at an earlier point in disease
development.
However, in this study the immunohistochemical
labelling of H- and L-type BSE differed substantially
from each other and from C-type BSE in other areas of
the central nervous system. Greater qualitative discrimi-
nation was possible examining more rostral areas of the
brain, and particularly the cerebellum, despite this area
not necessarily displaying the greatest amount of PrP
[43]. This offers the possibility of amending routine sur-
veillance sampling to include cerebellum taken through
the foramen magnum, as is currently required for sheep,
thereby enhancing the discriminatory potential of the
confirmatory testing. The presence of immunolabelling
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tent with C-type BSE. Current study design does not
allow ascertainment of whether this happens at an early
stage in the disease, or as a centrifugal spread in end-
stage disease as is speculated for C-type BSE [28,44,45].
The absence of detectable involvement of the lym-
phoreticular and enteric nervous system is consistent
with many observations for C-type BSE, and other
reports of experimental H-BSE [26] although for C-type
BSE it has also been demonstrated that infectivity can
be detected in the absence of identifiable PrP
d in in
vitro tests [46,47]. Besides, all cattle were challenged
intracerebrally, thus by-passing the gastro-intestinal
tract and possible uptake of the agent through the gut.
Interestingly, the H-type BSE challenged animals in
this study did not develop plaques like the animals in
another experimental challenge study conducted in
Japan [26], which also displayed shorter incubation peri-
ods and a more restricted range of clinical signs. Unlike
the Japanese study, we only used one antibody - the rat
monoclonal R145 which recognises the C-terminal of
PrP. However, the range of antibodies used in the Japa-
nese study all demonstrated strongly immunolabelled
plaque formations, despite more variation in intracellu-
lar labelling, so it would appear to be a specific morpho-
logical difference between the animals in these studies.
The very small number of animals represented in
these studies means that it can only be speculated
whether such changes reflect a degree of natural varia-
tion in the donor animals, or whether there are as yet
unrecognised influences from recipient host factors.
When Western immunoblotting is used for diagnostic
or confirmatory purposes, H-type BSE can readily be
identified by its characteristic profile even when the sig-
nal is strong. In contrast, the characteristics of L-type
BSE appear to be more subtle and the results here sug-
gest that when the signal is too intense it is not readily
differentiated by visual examination from a classical BSE
profile. This observation has led to the routine dilution
of samples from any positive BSE case that is subjected
to Western immunoblotting under UK surveillance in
order to maximise the opportunity for initial identifica-
tion of this form of atypical BSE and to allow such sam-
ples to be subjected to further investigation for full
characterisation.
Conclusions
Cattle experimentally infected by intracerebral inocula-
tion with L-type or H-type BSE present with two clinical
phenotypes, either dull or nervous forms, which may be
less clinically overt than classical BSE although difficulty
in rising is consistently displayed. This may explain the
detection of naturally occurring cases in apparently
healthy or emergency slaughter cattle and fallen stock.
Current screening and confirmatory diagnostic methods
are effective for the detection of such atypical cases, but
consistently and correctly identifying and discriminating
the variant forms may require modifications to the sam-
pling regimes and methods that are currently in use.
Methods
All procedures involving animals were approved by the
Home Office of the UK government according to the
Animal (Scientific Procedures) Act 1986.
Inocula
Brain homogenate (in 10% w/v solution in sterile saline)
was prepared from a French cow with H-type BSE
(code: ESB-H-07-0644) and an Italian cow with L-type
BSE (code: 141387/02). Prior to inoculation, the inocula
were either heat treated (twice for 15 minutes at 70°C;
H-type BSE) or treated with antibiotics (L-type BSE)
according to established methods [48].
Animals
Ten calves were born from heifers imported from Den-
mark (Danish Holstein, Danish milking red) that were
crossed with Aberdeen Angus. EDTA blood was col-
lected from each animal prior to inoculation for DNA
extraction to determine the PrP gene open reading
frame polymorphisms according to published methods
[35]. Groups of four calves were intracerebrally inocu-
lated with 1.0 ml of either L-type or H-type BSE brain
homogenate at 10-11 months of age; the remaining two
cattle were not inoculated and served as controls (for
inoculation procedure please refer to [48]).
Husbandry and routine procedures
Both inoculated groups were housed in medium security
accommodation with no contact to each other, with
separate pen entrances and separate equipment. Control
cattle were initially housed on pasture and later moved
to the medium security accommodation to serve as
companions of the last remaining inoculated steer in its
group. All housed cattle were given hay ad libitum and
a daily concentrate ration free from meat and bone
meal. Pens were cleaned out daily by husbandry staff.
Routine procedures included quarterly weighing of
housed cattle and regular blood sampling for archiving
purposes [quarterly up to 16 mpi, monthly thereafter].
Clinical assessments
All animals were clinically examined prior to inoculation
to confirm their suitability for the study.
Observations by husbandry staff
Animals were checked daily by animal husbandry staff
and any unusual behaviour during feeding or cleaning of
the pens was recorded in a daybook. This was extended
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housed cattle from 17 mpi when difficulty in getting up
was first noticed. A scoring system for the rising beha-
viour was used:
score 0 = getting up without delay, rising on hind
limbs first;
score 1 = slight difficulties getting up, e.g. the phase of
rising on the hind limbs seems to be delayed;
score 2 = obvious difficulties getting up with rising on
the fore limbs first or dragging the body along the floor
before getting up;
score 3 = unable to get up, the animal may attempt to
do so but does not succeed.
Neurological examinations
Neurological examinations were conducted quarterly
from 8 mpi and monthly from 17 mpi when the first
animal was culled at clinical end-point. Clinical exami-
nations consisted of a neurological examination accord-
ing to a standard protocol [48], which included
inspection of the retina and tests of over-reactivity, such
as testing the response to camera flash (’flash test’), to
hand clapping and a metallic bang, to a clipboard waved
in front of the animal (’clipboard test’) and to touching
of the hind limbs with a flexible stick (’stick test’) [49].
Behavioural observations
Behavioural observations for 15 minutes per pen to
assess the animals’ behaviour and mental status and
reactivity [48] were carried out weekly between 11 a.m.
and 12 noon from 9 mpi. Observations of the two con-
trols commenced from 19 mpi when they were moved
from the pasture. Observations were conducted without
interaction of the observer except for the ‘hand
approach test’ (moving the hand towards the animal
when close to the observer at the door) or the clipboard
test at the end of the observation period if an animal
did not approach.
Observations by closed circuit television
The two pens housing the inoculated cattle were moni-
tored during daytime by two cameras each (AXIS
209FD with Camera Station software version 3, AXIS
Communications, Lund, Sweden) mounted in opposite
corners. Weekly camera observations were conducted
from 16 mpi (for controls three months later) and com-
prised the study of selected animals’ behaviour and
activity associated with BSE [50] for 15 minutes between
10 a.m. and 12 noon (not on the same day as the beha-
vioural observations) as well as a scan of the same day
to assess the rising and lying down behaviour of each
animal. The scoring system for rising behaviour was
identical to that used by animal husbandry staff. Lying
down behaviour was scored as follows:
score 0 = lying down without delay or difficulty;
score 1 = trying to lie down but incomplete/gets up
again;
score 2 = goes down on knees then slow to lower
hindquarters.
Clinical end-point
Cattle were culled by intravenous injection of pentobar-
bitone when they reached clinical end-point, which was
documented in the Home Office project licence. Based
on previous experience with classical BSE, the end-point
was reached when cattle displayed signs in at least two
of the three categories ‘changes in mental status, beha-
viour and activity’, ‘changes in sensation’ and ‘changes
in posture and movement’. Euthanasia would also be
required if cattle displayed severe weakness likely to
cause recumbency, difficulty in eating or drinking or any
behaviour indicating pain or any other significant dis-
tress. Control cattle were culled when the last inocu-
lated animal was culled.
Postmortem diagnostic tests
Clinical chemistry and haematology
Blood was collected from each animal prior to cull for
routine haematological (including differential cell
count) and blood biochemical examination (liver
enzymes and CK, total protein, albumin and globulin,
urea, creatinine, bilirubin, b-hydroxybutyrate, selected
electrolytes and minerals, vitamin E, glutathione perox-
idase and fibrinogen and haptoglobin). Deviations from
‘normal’ values were based on published reference
ranges [51].
Histopathology and immunohistochemistry
The brain was removed and a piece of the medulla at
the level of the obex fixed in 10% formal saline for his-
topathological examination. The remainder of the brain
was either frozen at -80°C (second and fourth animal
culled in each group) or half fixed and half frozen (first
and third culled animal and controls). Sections repre-
senting standardised levels of the fixed brain [3,5] were
prepared from paraffin wax-embedded blocks using rou-
tine histological methods and stained with H&E for the
detection of vacuolar changes as described previously
[3]. Data generated from animals experimentally inocu-
l a t e dw i t hC - t y p eB S Eb yt h ei n t r a c e r e b r a lr o u t ei na
previous study [52,53] were used for comparison. This
same data was used previously as a comparator for
experimental scrapie in cattle [9].
Further sections were immunolabelled with the rat
anti-PrP mAb R145 (Animal Health and Veterinary
Laboratories Agency, Addlestone, UK) for the detection
of PrP
d as described in detail elsewhere [5,28].
Immunohistochemical examination was also per-
formed on spinal cord sampled at four levels (C6-7,T 4-5,
T9-10 and L2-3), mesenteric lymph node, distal ileum,
palatine tonsil, medial retropharyngeal lymph node, tri-
geminal ganglion and extraocular muscles, together with
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nosus muscles.
Western immunoblotting
Fresh, frozen samples of caudal medulla were processed
using the BioRad TeSeE universal Western blot kit
(BioRad Laboratories, Marnes-La-Coquette, France) fol-
lowing the manufacturers instructions. Essentially, the
samples were processed, electrophoresed, transferred
and detected with the following panel of mAbs. For H-
type samples; SHA31 targeting the PrP amino acid (aa)
residues 156-163 (BioRad Laboratories, included in the
kit), P4 (aa 97-112; R-BioPharm, Darmstadt, Germany)
and SAF84 (aa173-178; Cayman Chemicals, Ann Arbor,
U S A ) .F o rL - t y p eB S Es a m p l e s ;S H A 3 1 ,P 4 ,6 H 4( a a
155-163; Prionics, Schlieren-Zurich, Switzerland) and
F99 (aa 228-233; VMRD, Pullman, USA). Where neces-
sary, sample dilutions were carried out in Laemmli sam-
ple buffer (BioRad Laboratories) prior to loading on the
gel. The signal was visualised by chemoluminescence
and the image captured using a Fluor-S multiImager
(BioRad Laboratories). The 20% homogenate prepara-
tions from the L-type BSE cases were also subjected to
mild and stringent PK digestion conditions: stringent
digestion was 500 μg/ml PK at pH 8.0, and mild diges-
tion was 50 μg/ml PK at pH 6.5 prior to immunoblot-
ting, as described [12], and detected using mAbs L42
(aa 153-171; R-BioPharm), 6H4 and 94B4 (aa 198-205;
donated by Jan Langeveld, CVI Lelystad, Netherlands).
Quantity One software (BioRad Laboratories) was used
for analysis of the glycoprofiles and PK susceptibility
ratio, in accordance with the guidelines provided by the
TSE EU Reference Laboratory [54].
Additional material
Additional file 1: H-type BSE (H1) H-type BSE-inoculated steer at 17
mpi (prior to cull), ‘nervous form’. This steer displays head shyness in
the crush (over-reactivity when approached from the front) and tosses its
head in response to touching of the head with artery forceps. It displays
mildly apprehensive behaviour, characterised by stopping at grooves or
avoiding the drain on the floor (note also the mild startle with twitching
of the forelimbs after the animal vocalises in the corridor and trots
towards the camera). There is mild hind limb hypermetria. It has
considerable difficulty in rising, dragging its body along the floor of the
pen over a time period of approximately 2 minutes (rising score 2).
Additional file 2: L-type BSE (L1) L-type BSE-inoculated steer at 17
mpi (prior to cull), ‘nervous form’. This steer displays head shyness in
the crush (head shaking or tossing when observed from the front) and
over-reactivity to testing of the menace response and touching of the
head and upper neck with artery forceps. It refuses to walk towards the
end of the corridor (’freezes’) on its own but runs with hypermetric hind
limb movements in this direction when other cattle are led out. It has
considerable difficulty in rising (animal marked by arrow) with dragging
its body along the floor of the pen (rising score 2).
Additional file 3: Control (CO1) Control steer (not inoculated) at 23
months after inoculation of test groups. This steer mainly keeps its
head towards the floor of the crush during cranial nerve assessments
and there is only very mild over-reaction to testing of the menace
response. It is willing to run along the corridor, only stopping briefly to
inspect the door. It gets up without difficulty in the pen.
Additional file 4: H-type BSE (H4a) H-type BSE-inoculated steer at
18 and 20 mpi, ‘nervous form’. This steer startles and runs away after
approaching and sniffing the camera at the door whereas the
superimposed clip shows a control steer, observed in the pen for the
first time at the same day, slightly backs off after sniffing the camera.
Two months later it stands on its own in the other half of the pen and
displays a spontaneous whole body flinch.
Additional file 5: H-type BSE (H4b) H-type BSE-inoculated steer at
21 mpi (prior to cull), ‘dull form’. This steer stood for considerable
time in the pen with low head carriage whilst its pen mates were lying
ruminating in the other half of the pen. It does not rise upon entering
the pen when surrounded by its pen mates but rises when the rump is
touched, dragging its body along the floor (rising score 2). Cranial nerve
assessments are well tolerated. Its behaviour in the corridor is
unremarkable (no signs of apprehension). It displays mild hind limb
hypometria, best seen when the animal turns at the end of the corridor.
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